Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypertriglyceridemia: HELP
Bhakti Arondekar
Based on 5 articles published since 2008
||||
Expertise Level
The expertise of Bhakti Arondekar ranks in the
  • Top 1.9%
  • ... of 12,738 published authors worldwide on Hypertriglyceridemia
  • ... from 2008 through 2019
  • ... based on contributions to 5 articles on the topic.
Graphical view (beta)
Uncounted papers?
Work Locations
Details
Most likely:    GlaxoSmithKline      
2014
  • Clinical Effectiveness and Safety, GlaxoSmithKline, Durham, NC. Electronic address: · US Health Outcomes, GlaxoSmithKline, Philadelphia, Pa. · Health Economics and Outcomes, OptumInsight, Eden Prairie, Minn. · Department of Medicine, Emory University, Atlanta, Ga. · Medicines Discovery & Development, GlaxoSmithKline, Durham, NC. · Clinical Effectiveness and Safety, GlaxoSmithKline, Philadelphia, Pa. · Pubmed 24384100
2012
  • Clinical Effectiveness & Safety, GlaxoSmithKline, 5 Moore Drive, B.3116, Durham, NC 27709-3398, USA. · Pubmed 23009781
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Bhakti Arondekar in 2008-2019 about Hypertriglyceridemia:

  • Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia. 2014
  • Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemia. 2012
  • Hospital use and medical care costs up to 5 years after triglyceride lowering among patients with severe hypertriglyceridemia. 2012
  • Estimating health and economic benefits from using prescription omega-3 fatty acids in patients with severe hypertriglyceridemia. 2011
  • Patient characteristics and medical care costs associated with hypertriglyceridemia. 2011
Show List of Full Article Records
Google Searches

Learn more about Bhakti Arondekar using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
GlaxoSmithKline
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
GlaxoSmithKline
2014
  • Clinical Effectiveness and Safety, GlaxoSmithKline, Durham, NC. Electronic address: · US Health Outcomes, GlaxoSmithKline, Philadelphia, Pa. · Health Economics and Outcomes, OptumInsight, Eden Prairie, Minn. · Department of Medicine, Emory University, Atlanta, Ga. · Medicines Discovery & Development, GlaxoSmithKline, Durham, NC. · Clinical Effectiveness and Safety, GlaxoSmithKline, Philadelphia, Pa. · Pubmed 24384100
2012
  • Clinical Effectiveness & Safety, GlaxoSmithKline, 5 Moore Drive, B.3116, Durham, NC 27709-3398, USA. · Pubmed 23009781
4 Other Locations Show
Yearly article counts 000001022000
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.